Capital World Investors 13D and 13G filings for Regeneron Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 6:19 pm Sale | 2024-02-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 5,194,729 4.800% | -1,121,090 (-17.75%) | Filing |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 6,315,819 5.900% | 923,949 (+17.14%) | Filing |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 5,391,870 5.100% | -1,625,252 (-23.16%) | Filing |
| 2021-02-16 1:00 pm Sale | 2021-02-16 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 7,017,122 6.700% | -1,334,829 (-15.98%) | Filing |